DHR · Danaher Corporation
AI read · Good for DHR
The AI's read
Hospitals can add the test without buying new equipment or changing current testing steps. That could make it easier for labs to use, though the story gives no sales or uptake figures.
Beckman Coulter Diagnostics got the green light from the FDA for its Access MeMed BV® test to tell apart bacterial and viral infections.
Good for DHR
FDA clearance lets Danaher's Beckman Coulter offer the assay to clinicians treating adults and children, and it fits existing analyzers without workflow changes. The story gives no sales or uptake figures, but clearance and easy integration favor Danaher's diagnostics business.
Get alerts for DHR
Follow Danaher Corporation (DHR) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for DHRFree on the App Store and Google Play, or on the web.